Shorla Oncology raises $35m to accelerate growth
Founded in 2018 by Sharon Cunningham and Orlaith Ryan, Shorla has an advanced pipeline of innovative oncology drugs for rare, orphan and paediatric cancers
Shorla Oncology, an Irish-founded healthcare start-up that develops pharmaceutical therapies to help cancer patients, has raised $35 million (€33 million) to accelerate the growth of its portfolio of drugs.
The news comes just six months after the company secured FDA approval to bring a speciality drug designed to treat T-cell leukaemia, to market in the US.
Founded in 2018 by Sharon Cunningham and Orlaith Ryan, Shorla Oncology is a Clonmel, Tipperary and Cambridge, Massachusetts-based pharmaceutical ...